| |
| |
|
| Insider
Information: |
Western Standard Partners Qp, L.p. |
| Relationship: |
|
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
534,008 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$8,079,541 |
|
|
| Total
Shares |
534,008 |
|
|
| Total
Value |
$8,079,541 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merrimack Pharmaceuticals Inc |
MACK |
|
|
0 |
2023-12-28 |
534,008 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-11-09 |
4 |
B |
$12.19 |
$121,618 |
I/I |
9,975 |
437,202 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-11-10 |
4 |
B |
$12.32 |
$469,008 |
I/I |
38,062 |
445,461 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-11-13 |
4 |
B |
$12.39 |
$192,875 |
I/I |
15,570 |
448,840 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-11-14 |
4 |
B |
$12.50 |
$627,125 |
I/I |
50,170 |
459,727 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-11-17 |
4 |
B |
$12.50 |
$3,750 |
I/I |
300 |
459,792 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-12-07 |
4 |
B |
$12.85 |
$1,298,472 |
I/I |
101,050 |
484,458 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-12-26 |
4 |
B |
$13.15 |
$640,313 |
I/I |
48,693 |
533,151 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-12-28 |
4 |
B |
$13.35 |
$11,441 |
I/I |
857 |
534,008 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2021-07-01 |
4/A |
B |
$6.39 |
$338,120 |
I/I |
52,914 |
1,000,220 |
0.01 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2021-07-01 |
4/A |
S |
$6.39 |
$338,120 |
I/I |
(52,914) |
269,338 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-01-30 |
4/A |
B |
$11.36 |
$280,930 |
I/I |
24,735 |
323,883 |
0.01 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-01-31 |
4/A |
B |
$11.40 |
$25,444 |
I/I |
2,232 |
324,333 |
0.01 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
